1. Taylor EC, Harrington PJ, Fletcher SR, Beardsley GP, Moran RG: Synthesis of the antileukemic agents 5,10-dideaza-aminopterin and 5,10-dideaza-5,6,7,8-tetra hydroaminopterin. J Med Chem 28:914–921, 1985
2. Beardsley GP, Moroson BA, Taylor EC, Moran RG: A new antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de nova purine synthesis. J Biol Chem 264:328–333, 1989
3. Shih C, Grindey GB, Houghton PJ, Houghton JA: In vivo antitumor activity of 5,10-dideazatetrahydrofolic acid (DDATHF) and its diastereomeric isomers. Proc Am Assoc Cancer Res 29:283, 1988
4. Beardsley GP, Pizzorno G, Russello O, Cashmore AR, Moroson BA, Cross AD, Wildman D: Biochemical pharmacology of deazatetrahydrofolates. In: Curtius HC, Ghisla S, Blau N (eds) Chemistry and Biology of Pteridines. Walter de Gruyter and Co., Berlin, 1989, pp 1001–1008
5. Ray MS, Muggia FM, Leichman GC, Nelson RL, Dyke RW, Moran RG: Phase I study of 6(R)-5,10-dideazatetrahydrofolate: a folate antimetabolite inhibitory to de novo purine synthesis. J Natl Cancer Inst 85:1154–1159, 1993